EIR Takeda Pharmaceutical Company Oct 2003

George Flynn FDA, Richard Needham FDA$595.00 - Available Now

FDA investigators audited the Takeda Pharmaceutical Company - Osaka, Japan facility and issued inspectional observation (via FDA 483) on 17 Oct 2003.

Product details

  • Category:
  • Inspection end: 17 Oct 2003
  • Location: Osaka, Japan
  • FEI: 3002808311
Add To Cart